Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Cohort Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin in Patients With Advanced Non-Small Cell Lung Cancers and Malignant Pleural Mesotheliomas

NCT00281125 is registered in ClinicalTrials.gov with Nevada Cancer Institute as lead sponsor.

NCT NCT00281125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00281125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Cohort Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin in Patients With Advanced Non-Small Cell Lung Cancers and Malignant Pleural Mesotheliomas
Lead sponsor
Nevada Cancer Institute
Phase
Phase 1/2
Overall status
Terminated
Start date
January 31, 2006
Completion date
August 31, 2008
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer and pleural mesothelioma